NEW YORK (GenomeWeb) — Samplix of Denmark has won €1.9 million ($2.2 million) in funding from the European Union's Horizon 2020 – SME instrument program.
The company plans to use the funding to further develop its Xdrop technology, which allows users to partition millions of single molecules in droplets for targeted enrichment and amplification for sequencing analysis.
The Xdrop technology, which is currently in beta testing with several research institutes, comprises microfluidics, chemistry, and bioinformatics.
Samplix is one of 278 small and medium-sized enterprises from 27 countries receiving funding as part of this round, announced in late December, which totaled €129 million under Phase 2 and €10 million under Phase 1.